Posts Tagged ‘Dermatology’

Almirall reaches an agreement to acquire 100% of Poli Group

Agreement to acquire 100% of the share capital of Poli Group Holding S.r.l. Acquisition will bring added revenues, a growth portfolio and complementary skills in Dermatology OTC. Almirall will also obtain a Dermatology focused R&D structure with proprietary formulation technology (HPCH) and three clinical stage pipeline projects. Transaction significantly accretive to Adjusted EPS in the […]

Almirall has acquired the rights to Veltin® and Altabax® from Stiefel, a GSK company, in exchange for its distribution rights to Toctino®

The addition of these two products will significantly enhance Almirall’s Dermatology business, and contribute to Almirall’s vision to become a leading player in Dermatology. Veltin® and Altabax® will be commercialised through Aqua Pharmaceuticals, Almirall’s US affiliate. Both medicines are a perfect fit with our current portfolio, are aligned with our global strategy and strengthen our […]